RALEIGH, N.C. – June 30, 2026 – With days left to act in the legislative session, cancer advocates urgently call on North Carolina lawmakers to pass legislation improving access to biomarker testing.
Today, legislation aiming to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans, was voted out of committee and will soon be heard by the full House. This marks the final step before the bill goes to Governor Matt Meyer who, earlier this year, identified biomarker testing access as a priority.
SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.
DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Tras meses de debate, los legisladores estatales finalizaron el presupuesto del estado de Nueva York, optando por preservar el acceso a las pruebas de biomarcadores para las personas inscritas en Medicaid.
La Legislatura de Illinois aprobó un proyecto de ley para incrementar el acceso a las pruebas de biomarcadores, una herramienta transformadora en la lucha contra el cáncer y otras enfermedades, y un paso esencial para acceder a tratamientos de precisión.
Late Friday, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released a final rule on the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2027.
Visual Elements Available for Download:
Cancer Advocates Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer
NASHVILLE, Tenn. – Gov.